Abstract Lymphangioleiomyomatosis (LAM) is a rare progressive disease, characterized by mutations in the tuberous sclerosis complex genes ( Tsc1 or Tsc2 ), and hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1). The effectiveness of mTORC1 inhibitors is limited by their lack of cy...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!